Clinical Trials Directory

Trials / Completed

CompletedNCT03471949

Dexcom G4 in a Population With Normal Oral Glucose Tolerance Test

Evaluation of the Profile of Blood Glucose Using Dexcom G4 in a Population With Normal Oral Glucose Tolerance Test

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Vastra Gotaland Region · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to obtain reference values of CGM in healthy individuals using the Dexcom G4 sensor and evaluate whether reported low glucose values by the Dexcom G4 sensor are really low when confirmed by capillary testing.

Detailed description

Evaluation of the profile of blood glucose using Dexcom G4 in a population with normal oral glucose tolerance test. The investigators have used information from a previous study of 60 participants using Dexcom G4, CGM system. A non-randomized, days 1-7 blinded and days 8-14 non-blinded CGM trial, the study was performed to evaluate the profile of blood glucose using CGM in the population with normal oral glucose tolerance test (OGTT). All enrolled subjects with at least three time-points with evaluable values from CGM system and the reference capillary value obtained from HemoCue during the whole study period were included in the Intent-to-Treat (ITT) population

Conditions

Interventions

TypeNameDescription
OTHERCGM in a population with normal OGTTThe population with normal OGTT will use CGM and document their values as well as be documenting a capillary blood glucose value

Timeline

Start date
2016-10-24
Primary completion
2018-12-11
Completion
2018-12-11
First posted
2018-03-21
Last updated
2019-04-25

Source: ClinicalTrials.gov record NCT03471949. Inclusion in this directory is not an endorsement.